Ben
Analyst
Citi
Equibles does not estimate personal net worth.
About Ben
Ben is recorded as Analyst at Citi. Ben has spoken on 2 earnings calls across 2 companies, most recently for SAB Biotherapeutics, Inc. on August 6, 2026. Those appearances were for SAB Biotherapeutics, Inc. (SABS) and Catalyst Pharmaceuticals, Inc.. The companies whose calls Ben spoke on are classified in the Healthcare sector.
Ben on recent calls
“Can you talk about the population you're enrolling in the PRI study and how it compares to Safeguard? Other than the time since diagnosis, how similar are these populations, and should we expect them to have less beta cell function, or is that not always the case?”
“To start, can you speak to the drivers that underpin the growth implied within your 2026 guidance for FURDAS and Agamory?”
Affiliation history
-
Citi
Analyst
Transcript header (unverified)
Current
Company network
Catalyst Pharmaceuticals, Inc.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-02-26
Recent activity
-
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Catalyst Pharmaceuticals, Inc.